{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:12:30Z","timestamp":1779909150120,"version":"3.53.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Young Elite Scientist Sponsorship Program by cs"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003645"],"award-info":[{"award-number":["82003645"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82293635"],"award-info":[{"award-number":["82293635"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92169211"],"award-info":[{"award-number":["92169211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Young Elite Scientist Sponsorship Program by cs"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The high mortality caused by severe COVID-19 poses great challenges to the public health. However, the underlying pathogenesis of severe cases remains unclear. Here, we find that SARS-CoV-2 infection boosts CD147 inducible up-regulation in the lung tissues of virus-infected rhesus macaques coupled with down-regulated membrane-bound ACE2, which conduces to extended virus infection and severe pathological lesions. Specifically, SARS-CoV-2 infection enhances the expression of transcriptional factor aryl hydrocarbon receptor and facilitates its nucleus translocation, which causes CD147 gene transcription and its up-regulation in protein level, thereby leading to virus susceptibility of the hosts and extended virus infection. Meanwhile, SARS-CoV-2 infection triggers immune imbalance of lung tissues by promoting cell death of CD4\u2009+\u2009T cells and B cells and mediating abnormal cell-cell communications, especially for M2 macrophages. Meplazumab, a humanized anti-CD147 antibody, effectively inhibits virus entry and cytokine level, and restores immune balance in the lung tissues of virus-infected rhesus macaque model. Importantly, we further present the cryo-EM structure of CD147-spike complex, and identify five pairs of functional residues for their interaction, which could be interrupted by Meplazumab via steric hindrance effect. Our findings provide direct evidence for CD147-SARS-CoV-2 spike interaction and uncover the pathogenesis of severe COVID-19 caused by CD147-mediated extended virus infection.<\/jats:p>","DOI":"10.1038\/s41392-025-02551-x","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:02:44Z","timestamp":1770076964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inducible CD147 up-regulation boosts extended SARS-CoV-2 infection triggering severe COVID-19 independent of ACE2"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8913-7115","authenticated-orcid":false,"given":"Ke","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6471-4104","authenticated-orcid":false,"given":"Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4880-824X","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4869-3777","authenticated-orcid":false,"given":"Linlin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9769-5141","authenticated-orcid":false,"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-1232","authenticated-orcid":false,"given":"Chuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejie","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6969-8177","authenticated-orcid":false,"given":"Zhiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0440-0306","authenticated-orcid":false,"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4690-4622","authenticated-orcid":false,"given":"Huijie","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"2551_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s15010-024-02223-y","volume":"52","author":"D Hattab","year":"2024","unstructured":"Hattab, D., Amer, M., Al-Alami, Z. M. & Bakhtiar, A. SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants. Infection. 52, 767\u2013786 (2024).","journal-title":"Infection."},{"key":"2551_CR2","doi-asserted-by":"publisher","first-page":"101850","DOI":"10.1016\/j.xcrm.2024.101850","volume":"5","author":"AL Roederer","year":"2024","unstructured":"Roederer, A. L. et al. Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity. Cell Rep. Med. 5, 101850 (2024).","journal-title":"Cell Rep. Med."},{"key":"2551_CR3","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.abm8108","volume":"375","author":"M Merad","year":"2022","unstructured":"Merad, M., Blish, C. A., Sallusto, F. & Iwasaki, A. The immunology and immunopathology of COVID-19. Science. 375, 1122\u20131127 (2022).","journal-title":"Science."},{"key":"2551_CR4","doi-asserted-by":"publisher","first-page":"2439541","DOI":"10.1080\/07853890.2024.2439541","volume":"57","author":"I Gentile","year":"2025","unstructured":"Gentile, I. et al. Early combination of sotrovimab with nirmatrelvir\/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study. Ann. Med. 57, 2439541 (2025).","journal-title":"Ann. Med."},{"key":"2551_CR5","doi-asserted-by":"crossref","unstructured":"Sigal, A., Neher, R. A. & Lessells, R. J. The consequences of SARS-CoV-2 within-host persistence. Nat. Rev. Microbiol. (2024).","DOI":"10.1038\/s41579-024-01125-y"},{"key":"2551_CR6","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1016\/S1473-3099(23)00815-0","volume":"24","author":"HM Machkovech","year":"2024","unstructured":"Machkovech, H. M. et al. Persistent SARS-CoV-2 infection: significance and implications. Lancet Infect. Dis. 24, e453\u2013e462 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"2551_CR7","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41586-024-07029-4","volume":"626","author":"M Ghafari","year":"2024","unstructured":"Ghafari, M. et al. Prevalence of persistent SARS-CoV-2 in a large community surveillance study. Nature. 626, 1094\u20131101 (2024).","journal-title":"Nature."},{"key":"2551_CR8","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.3390\/jcm13237124","volume":"13","author":"F Serapide","year":"2024","unstructured":"Serapide, F. et al. Lights and Shadows of Long COVID: Are Latent Infections the Real Hidden Enemy?. J. Clin. Med. 13, 7124 (2024).","journal-title":"J. Clin. Med."},{"key":"2551_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-022-04802-1","volume":"606","author":"E Sefik","year":"2022","unstructured":"Sefik, E. et al. Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature. 606, 585\u2013593 (2022).","journal-title":"Nature."},{"key":"2551_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","volume":"19","author":"H Yang","year":"2021","unstructured":"Yang, H. & Rao, Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat. Rev. Microbiol. 19, 685\u2013700 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"2551_CR11","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/infdis\/jiaa804","volume":"223","author":"HC Maltezou","year":"2021","unstructured":"Maltezou, H. C. et al. Association Between Upper Respiratory Tract Viral Load, Comorbidities, Disease Severity, and Outcome of Patients With SARS-CoV-2 Infection. J. Infect. Dis. 223, 1132\u20131138 (2021).","journal-title":"J. Infect. Dis."},{"key":"2551_CR12","doi-asserted-by":"publisher","first-page":"m1443","DOI":"10.1136\/bmj.m1443","volume":"369","author":"S Zheng","year":"2020","unstructured":"Zheng, S. et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. Bmj. 369, m1443 (2020).","journal-title":"Bmj."},{"key":"2551_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/joim.13820","volume":"296","author":"H Viermyr","year":"2024","unstructured":"Viermyr, H. et al. High viral loads combined with inflammatory markers predict disease severity in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial. J. Intern. Med. 296, 249\u2013259 (2024).","journal-title":"J. Intern. Med."},{"key":"2551_CR14","doi-asserted-by":"publisher","first-page":"1108716","DOI":"10.3389\/fimmu.2023.1108716","volume":"14","author":"MH Shakiba","year":"2023","unstructured":"Shakiba, M. H., Gemund, I., Beyer, M. & Bonaguro, L. Lung T cell response in COVID-19. Front. Immunol. 14, 1108716 (2023).","journal-title":"Front. Immunol."},{"key":"2551_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186\u2013193 (2022).","journal-title":"Nat. Immunol."},{"key":"2551_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s13238-020-00738-2","volume":"11","author":"H Qin","year":"2020","unstructured":"Qin, H. & Zhao, A. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics. Protein Cell 11, 707\u2013722 (2020).","journal-title":"Protein Cell"},{"key":"2551_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev-immunol-083122-043545","volume":"42","author":"R Malireddi","year":"2024","unstructured":"Malireddi, R., Sharma, B. R. & Kanneganti, T. D. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19. Annu. Rev. Immunol. 42, 615\u2013645 (2024).","journal-title":"Annu. Rev. Immunol."},{"key":"2551_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","volume":"184","author":"R Karki","year":"2021","unstructured":"Karki, R. et al. Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes. Cell. 184, 149\u2013168 (2021).","journal-title":"Cell."},{"key":"2551_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41392-021-00726-w","volume":"6","author":"M Tian","year":"2021","unstructured":"Tian, M. et al. HIF-1alpha promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal Transduct. Target. Ther. 6, 308 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2551_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2636-4","volume":"11","author":"H Shi","year":"2020","unstructured":"Shi, H. et al. The inhibition of IL-2\/IL-2R gives rise to CD8(\u2009+\u2009) T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia. Cell Death Dis 11, 429 (2020).","journal-title":"Cell Death Dis"},{"key":"2551_CR21","doi-asserted-by":"publisher","first-page":"e84790","DOI":"10.7554\/eLife.84790","volume":"12","author":"NS Brunetti","year":"2023","unstructured":"Brunetti, N. S. et al. SARS-CoV-2 uses CD4 to infect T helper lymphocytes. Elife. 12, e84790 (2023).","journal-title":"Elife."},{"key":"2551_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41392-021-00760-8","volume":"6","author":"J Geng","year":"2021","unstructured":"Geng, J. et al. CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma. Signal Transduct. Target. Ther. 6, 347 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2551_CR23","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri, L. et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 370, 856\u2013860 (2020).","journal-title":"Science."},{"key":"2551_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.abd3072","volume":"370","author":"JL Daly","year":"2020","unstructured":"Daly, J. L. et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 370, 861\u2013865 (2020).","journal-title":"Science."},{"key":"2551_CR25","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/s42255-020-00324-0","volume":"2","author":"C Wei","year":"2020","unstructured":"Wei, C. et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat. Metab. 2, 1391\u20131400 (2020).","journal-title":"Nat. Metab."},{"key":"2551_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","volume":"31","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res 31, 126\u2013140 (2021).","journal-title":"Cell Res"},{"key":"2551_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 181, 271\u2013280 (2020).","journal-title":"Cell."},{"key":"2551_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53033-7","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86\/JN.1 and EG.5.1\/HK.3. Nat. Commun. 15, 8728 (2024).","journal-title":"Nat. Commun."},{"key":"2551_CR29","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"M Gheblawi","year":"2020","unstructured":"Gheblawi, M. et al. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ. Res. 126, 1456\u20131474 (2020).","journal-title":"Circ. Res."},{"key":"2551_CR30","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2023.01.039","volume":"186","author":"GY Oudit","year":"2023","unstructured":"Oudit, G. Y., Wang, K., Viveiros, A., Kellner, M. J. & Penninger, J. M. Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic. Cell. 186, 906\u2013922 (2023).","journal-title":"Cell."},{"key":"2551_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/CS20200482","volume":"135","author":"RK Sharma","year":"2021","unstructured":"Sharma, R. K. et al. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases. Clin. Sci. (Lond). 135, 1\u201317 (2021).","journal-title":"Clin. Sci. (Lond)."},{"key":"2551_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","volume":"5","author":"K Wang","year":"2020","unstructured":"Wang, K. et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct. Target. Ther. 5, 283 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2551_CR33","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1080\/22221751.2022.2059403","volume":"11","author":"YQ Zhou","year":"2022","unstructured":"Zhou, Y. Q. et al. SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner. Emerg. Microbes Infect. 11, 1135\u20131144 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"2551_CR34","doi-asserted-by":"publisher","first-page":"e2122236119","DOI":"10.1073\/pnas.2122236119","volume":"119","author":"MG Andrews","year":"2022","unstructured":"Andrews, M. G. et al. Tropism of SARS-CoV-2 for human cortical astrocytes. Proc. Natl. Acad. Sci. USA 119, e2122236119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2551_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.34133\/research.0167","volume":"6","author":"C Chen","year":"2023","unstructured":"Chen, C. et al. CD147 Facilitates the Pathogenesis of Psoriasis through Glycolysis and H3K9me3 Modification in Keratinocytes. Research. 6, 167 (2023).","journal-title":"Research."},{"key":"2551_CR36","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41423-018-0012-4","volume":"16","author":"N Guo","year":"2019","unstructured":"Guo, N. et al. A critical epitope in CD147 facilitates memory CD4(\u2009+\u2009) T-cell hyper-activation in rheumatoid arthritis. Cell. Mol. Immunol. 16, 568\u2013579 (2019).","journal-title":"Cell. Mol. Immunol."},{"key":"2551_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/CIRCRESAHA.123.323223","volume":"134","author":"JJ Lv","year":"2024","unstructured":"Lv, J. J. et al. CD147 Sparks Atherosclerosis by Driving M1 Phenotype and Impairing Efferocytosis. Circ. Res. 134, 165\u2013185 (2024).","journal-title":"Circ. Res."},{"key":"2551_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41392-021-00740-y","volume":"6","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker. Signal Transduct. Target. Ther. 6, 315 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2551_CR39","doi-asserted-by":"publisher","first-page":"1367734","DOI":"10.3389\/fimmu.2024.1367734","volume":"15","author":"L Xu","year":"2024","unstructured":"Xu, L. et al. Role of aryl hydrocarbon receptors in infection and inflammation. Front. Immunol. 15, 1367734 (2024).","journal-title":"Front. Immunol."},{"key":"2551_CR40","doi-asserted-by":"publisher","first-page":"eadf0211","DOI":"10.1126\/sciadv.adf0211","volume":"9","author":"J Shi","year":"2023","unstructured":"Shi, J. et al. Aryl hydrocarbon receptor is a proviral host factor and a candidate pan-SARS-CoV-2 therapeutic target. Sci. Adv. 9, eadf0211 (2023).","journal-title":"Sci. Adv."},{"key":"2551_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25412-x","volume":"12","author":"F Giovannoni","year":"2021","unstructured":"Giovannoni, F. et al. AHR signaling is induced by infection with coronaviruses. Nat. Commun. 12, 5148 (2021).","journal-title":"Nat. Commun."},{"key":"2551_CR42","doi-asserted-by":"publisher","first-page":"115798","DOI":"10.1016\/j.bcp.2023.115798","volume":"216","author":"CA Opitz","year":"2023","unstructured":"Opitz, C. A., Holfelder, P., Prentzell, M. T. & Trump, S. The complex biology of aryl hydrocarbon receptor activation in cancer and beyond. Biochem. Pharmacol. 216, 115798 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"2551_CR43","doi-asserted-by":"publisher","first-page":"624293","DOI":"10.3389\/fimmu.2021.624293","volume":"12","author":"MF Torti","year":"2021","unstructured":"Torti, M. F., Giovannoni, F., Quintana, F. J. & Garcia, C. C. The Aryl Hydrocarbon Receptor as a Modulator of Anti-viral Immunity. Front. Immunol. 12, 624293 (2021).","journal-title":"Front. Immunol."},{"key":"2551_CR44","doi-asserted-by":"publisher","first-page":"1130398","DOI":"10.3389\/fimmu.2023.1130398","volume":"14","author":"Y Sun","year":"2023","unstructured":"Sun, Y., Luo, B., Liu, Y., Wu, Y. & Chen, Y. Immune damage mechanisms of COVID-19 and novel strategies in prevention and control of epidemic. Front. Immunol. 14, 1130398 (2023).","journal-title":"Front. Immunol."},{"key":"2551_CR45","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-024-01888-z","volume":"9","author":"J Su","year":"2024","unstructured":"Su, J. et al. Cell-cell communication: new insights and clinical implications. Signal Transduct. Target. Ther. 9, 196 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2551_CR46","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1016\/j.cell.2023.06.005","volume":"186","author":"J Baggen","year":"2023","unstructured":"Baggen, J. et al. TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry. Cell. 186, 3427\u20133442 (2023).","journal-title":"Cell."},{"key":"2551_CR47","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1182\/blood-2017-08-802918","volume":"131","author":"M Zhang","year":"2018","unstructured":"Zhang, M. et al. Disrupting CD147-RAP2 interaction abrogates erythrocyte invasion by Plasmodium falciparum. Blood. 131, 1111\u20131121 (2018).","journal-title":"Blood."},{"key":"2551_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41392-023-01323-9","volume":"8","author":"H Bian","year":"2023","unstructured":"Bian, H. et al. Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2\/3, randomized, third-party double-blind clinical trial. Signal Transduct. Target. Ther. 8, 46 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2551_CR49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41392-021-00603-6","volume":"6","author":"H Bian","year":"2021","unstructured":"Bian, H. et al. Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial. Signal Transduct. Target. Ther. 6, 194 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2551_CR50","doi-asserted-by":"publisher","first-page":"115745","DOI":"10.1016\/j.bcp.2023.115745","volume":"216","author":"A Alluli","year":"2023","unstructured":"Alluli, A., Rijnbout, S. J. W., Eidelman, D. H. & Baglole, C. J. Dynamic relationship between the aryl hydrocarbon receptor and long noncoding RNA balances cellular and toxicological responses. Biochem. Pharmacol. 216, 115745 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"2551_CR51","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s12276-023-01028-7","volume":"55","author":"SK Seo","year":"2023","unstructured":"Seo, S. K. & Kwon, B. Immune regulation through tryptophan metabolism. Exp. Mol. Med. 55, 1371\u20131379 (2023).","journal-title":"Exp. Mol. Med."},{"key":"2551_CR52","doi-asserted-by":"crossref","unstructured":"Anderson, G., Carbone, A. & Mazzoccoli, G. Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology. Int. J. Mol. Sci. 22, 1597 (2021).","DOI":"10.3390\/ijms22041597"},{"key":"2551_CR53","doi-asserted-by":"publisher","first-page":"111535","DOI":"10.1016\/j.intimp.2024.111535","volume":"128","author":"Y He","year":"2024","unstructured":"He, Y. et al. ACE2 improves endothelial cell function and reduces acute lung injury by downregulating FAK expression. Int. Immunopharmacol. 128, 111535 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"2551_CR54","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.121.18295","volume":"79","author":"K Wang","year":"2022","unstructured":"Wang, K. et al. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries. Hypertension. 79, 365\u2013378 (2022).","journal-title":"Hypertension."},{"key":"2551_CR55","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","volume":"23","author":"MS Diamond","year":"2022","unstructured":"Diamond, M. S. & Kanneganti, T. D. Innate immunity: the first line of defense against SARS-CoV-2. Nat. Immunol. 23, 165\u2013176 (2022).","journal-title":"Nat. Immunol."},{"key":"2551_CR56","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41423-023-01104-y","volume":"21","author":"BL Sievers","year":"2024","unstructured":"Sievers, B. L., Cheng, M., Csiba, K., Meng, B. & Gupta, R. K. SARS-CoV-2 and innate immunity: the good, the bad, and the \u201cgoldilocks\u201d. Cell. Mol. Immunol. 21, 171\u2013183 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"2551_CR57","doi-asserted-by":"publisher","first-page":"e34577","DOI":"10.1016\/j.heliyon.2024.e34577","volume":"10","author":"J Zhang","year":"2024","unstructured":"Zhang, J. Immune responses in COVID-19 patients: Insights into cytokine storms and adaptive immunity kinetics. Heliyon. 10, e34577 (2024).","journal-title":"Heliyon."},{"key":"2551_CR58","doi-asserted-by":"crossref","unstructured":"Wu, T. T. et al. Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung. J. Exp. Med. 221, e20232192 (2024).","DOI":"10.1084\/jem.20232192"},{"key":"2551_CR59","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1038\/s41590-023-01661-4","volume":"24","author":"N Huot","year":"2023","unstructured":"Huot, N. et al. SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-gamma and NK cells. Nat. Immunol. 24, 2068\u20132079 (2023).","journal-title":"Nat. Immunol."},{"key":"2551_CR60","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 581, 215\u2013220 (2020).","journal-title":"Nature."},{"key":"2551_CR61","doi-asserted-by":"crossref","unstructured":"Barton, M. I. et al. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Elife. 10, e70658 (2021).","DOI":"10.7554\/eLife.70658"},{"key":"2551_CR62","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","volume":"29","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe 29, 463\u2013476 (2021).","journal-title":"Cell Host Microbe"},{"key":"2551_CR63","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1107\/S2059798316019276","volume":"73","author":"R Fernandez-Leiro","year":"2017","unstructured":"Fernandez-Leiro, R. & Scheres, S. H. W. A pipeline approach to single-particle processing in RELION. Acta Crystallogr. Sect. D-Struct. Biol. 73, 496\u2013502 (2017).","journal-title":"Acta Crystallogr. Sect. D-Struct. Biol."},{"key":"2551_CR64","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods. 14, 331\u2013332 (2017).","journal-title":"Nat. Methods."},{"key":"2551_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K., Gctf & Real-time, C. T. F. determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"2551_CR66","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"2551_CR67","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.str.2008.03.005","volume":"16","author":"LG Trabuco","year":"2008","unstructured":"Trabuco, L. G., Villa, E., Mitra, K., Frank, J. & Schulten, K. Flexible fitting of atomic structures into electron microscopy maps using molecular dynamics. Structure. 16, 673\u2013683 (2008).","journal-title":"Structure."},{"key":"2551_CR68","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nature17970","volume":"533","author":"Y He","year":"2016","unstructured":"He, Y. et al. Near-atomic resolution visualization of human transcription promoter opening. Nature. 533, 359\u2013365 (2016).","journal-title":"Nature."},{"key":"2551_CR69","doi-asserted-by":"publisher","first-page":"e43542","DOI":"10.7554\/eLife.43542","volume":"8","author":"M Igaev","year":"2019","unstructured":"Igaev, M., Kutzner, C., Bock, L. V., Vaiana, A. C. & Grubmuller, H. Automated cryo-EM structure refinement using correlation-driven molecular dynamics. Elife 8, e43542 (2019).","journal-title":"Elife"},{"key":"2551_CR70","doi-asserted-by":"publisher","first-page":"e2401150","DOI":"10.1002\/advs.202401150","volume":"11","author":"N Li","year":"2024","unstructured":"Li, N. et al. Four Parallel Pathways in T4 Ligase-Catalyzed Repair of Nicked DNA with Diverse Bending Angles. Adv. Sci. 11, e2401150 (2024).","journal-title":"Adv. Sci."},{"key":"2551_CR71","doi-asserted-by":"publisher","first-page":"19216","DOI":"10.1021\/acs.jmedchem.4c01652","volume":"67","author":"Z Zeng","year":"2024","unstructured":"Zeng, Z. et al. Advancing Cancer Immunotherapy through Engineering New PD-L1 Degraders: A Comprehensive Study from Small Molecules to PD-L1-Specific Peptide-Drug Conjugates. J. Med. Chem. 67, 19216\u201319233 (2024).","journal-title":"J. Med. Chem."},{"key":"2551_CR72","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang, E. et al. End-Point Binding Free Energy Calculation with MM\/PBSA and MM\/GBSA: Strategies and Applications in Drug Design. Chem. Rev. 119, 9478\u20139508 (2019).","journal-title":"Chem. Rev."},{"key":"2551_CR73","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors. Cell Syst 8, 329\u2013337 (2019).","journal-title":"Cell Syst"},{"key":"2551_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36560-7","volume":"14","author":"Z Xun","year":"2023","unstructured":"Xun, Z. et al. Reconstruction of the tumor spatial microenvironment along the malignant-boundary-nonmalignant axis. Nat. Commun. 14, 933 (2023).","journal-title":"Nat. Commun."},{"key":"2551_CR75","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","volume":"40","author":"DM Cable","year":"2022","unstructured":"Cable, D. M. et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat. Biotechnol. 40, 517\u2013526 (2022).","journal-title":"Nat. Biotechnol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02551-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02551-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02551-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:02:46Z","timestamp":1770076966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02551-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2551"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02551-x","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X.C. is a founder and shareholder of Jiangsu Pacific Meinuoke Biopharmaceutical Co., Ltd., and H.T. is an employee of Jiangsu Pacific Meinuoke Biopharmaceutical Co., Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}